These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 2537494

  • 1. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.
    Huff AC, Leatherwood JK, Kreuzer KN.
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1307-11. PubMed ID: 2537494
    [Abstract] [Full Text] [Related]

  • 2. Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA.
    Huff AC, Ward RE, Kreuzer KN.
    Mol Gen Genet; 1990 Mar; 221(1):27-32. PubMed ID: 2157956
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases.
    Huff AC, Kreuzer KN.
    J Biol Chem; 1990 Nov 25; 265(33):20496-505. PubMed ID: 2173709
    [Abstract] [Full Text] [Related]

  • 4. Mutations of the bacteriophage T4 type II DNA topoisomerase that alter sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide and an antibacterial quinolone.
    Freudenreich CH, Chang C, Kreuzer KN.
    Cancer Res; 1998 Mar 15; 58(6):1260-7. PubMed ID: 9515814
    [Abstract] [Full Text] [Related]

  • 5. Mutagenicity of topoisomerase-active agents in bacteriophage T4.
    DeMarini DM, Lawrence BK.
    Teratog Carcinog Mutagen; 1988 Mar 15; 8(5):293-301. PubMed ID: 2905838
    [Abstract] [Full Text] [Related]

  • 6. Role of recombinational repair in sensitivity to an antitumour agent that inhibits bacteriophage T4 type II DNA topoisomerase.
    Neece SH, Carles-Kinch K, Tomso DJ, Kreuzer KN.
    Mol Microbiol; 1996 Jun 15; 20(6):1145-54. PubMed ID: 8809767
    [Abstract] [Full Text] [Related]

  • 7. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M, Chan D, Andersson BS, Beran M, Silberman L, Estey E, Ricketts L, Zwelling LA.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4067-77. PubMed ID: 2825713
    [Abstract] [Full Text] [Related]

  • 8. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S, Riou G.
    Biochem Pharmacol; 1994 Aug 30; 48(5):975-84. PubMed ID: 8093110
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.
    Yamashita Y, Kawada S, Fujii N, Nakano H.
    Biochemistry; 1991 Jun 18; 30(24):5838-45. PubMed ID: 1646001
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D, Riou JF, Ahomadegbe JC, Zhou DY, Benard J, Riou G.
    Biochem Pharmacol; 1991 Jun 15; 41(12):1967-79. PubMed ID: 1645555
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Bakic M, Beran M, Andersson BS, Silberman L, Estey E, Zwelling LA.
    Biochem Biophys Res Commun; 1986 Jan 29; 134(2):638-45. PubMed ID: 3004458
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Nelson EM, Tewey KM, Liu LF.
    Proc Natl Acad Sci U S A; 1984 Mar 29; 81(5):1361-5. PubMed ID: 6324188
    [Abstract] [Full Text] [Related]

  • 16. Bacteriophage T4, a model system for understanding the mechanism of type II topoisomerase inhibitors.
    Kreuzer KN.
    Biochim Biophys Acta; 1998 Oct 01; 1400(1-3):339-47. PubMed ID: 9748648
    [Abstract] [Full Text] [Related]

  • 17. Identification of the breakage-reunion subunit of T4 DNA topoisomerase.
    Rowe TC, Tewey KM, Liu LF.
    J Biol Chem; 1984 Jul 25; 259(14):9177-81. PubMed ID: 6086624
    [Abstract] [Full Text] [Related]

  • 18. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.